ELIZABETH BISHOP: Open Payments
NPI 1013150663 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,272 in 216 payments from 19 companies in 2025. Trend: 2023 $2,726 · 2024 $2,475 · 2025 $4,272
Food & beverage: $3,222Consulting: $1,050
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $1,459 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 52 | $518 |
| ABBVIE INC. | 28 | $509 |
| Celltrion USA Inc. | 22 | $320 |
| Aimmune Therapeutics, Inc. | 35 | $277 |
| GENZYME CORPORATION | 9 | $269 |
| PFIZER INC. | 21 | $243 |
| Ipsen Biopharmaceuticals, Inc | 7 | $187 |
| Gilead Sciences, Inc. | 6 | $127 |
| QOL Medical, LLC | 4 | $93 |
Products named: TREMFYA, XIFAXAN, DUPIXENT, VEGZELMA, MAVYRET, ZENPEP, VELSIPITY, IQIRVO.
Industry payments across TX — which companies pay providers there.
